Treating gliomas with vaccines- ongoing clinical trials

 There are several ongoing clinical trials for GBM glioma vaccine treatment. One recent global clinical trial concluded that a vaccine can potentially give patients years of extra life^[1]. Another study conducted a review of current vaccine trials in glioblastoma and found that there have been many promising phase I and phase II GBM vaccine studies that have led to ongoing and upcoming phase III trials^[2]. Additionally, a recent article outlined the progress in GBM vaccine tumor therapy research and described the most clinically available dendritic cell vaccine clinical trial^[3].

Sources:

1. https://www.theguardian.com/science/2022/nov/17/vaccine-shown-to-prolong-life-patients-aggressive-brain-cancer-trial-glioblastoma

2. https://pubmed.ncbi.nlm.nih.gov/24804271/

3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766628/